CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis

This publication has 26 references indexed in Scilit:

• Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy
  Haematologica, 2012
• Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: Reversing tumor-induced defects
  Clinical Immunology, 2011
• Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
  Clinical Immunology, 2011
• CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
  PLOS ONE, 2011
• Tumor Evasion from T Cell Surveillance
  BioMed Research International, 2011
• LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
  Blood, 2010
• Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma
  American Journal of Hematology, 2010
• High Lymphoid Enhancer-Binding Factor-1 Expression Is Associated with Disease Progression and Poor Prognosis in Chronic Lymphocytic Leukemia
  Hematology Reports, 2010
• Regulation of multiple myeloma survival and progression by CD1d
  Blood, 2009
• Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
  Blood, 2008